ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano-Immunoadjuvant.

Jingjing Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.